Senior Clinical Trial Manager at Arcellx

Redwood City, California, United States

Arcellx Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Skills

Key technologies and capabilities for this role

Clinical Trial ManagementBudget ManagementTimeline ManagementVendor ManagementProject ManagementCommunicationRegulatory Compliance

Questions & Answers

Common questions about this position

What is the salary for the Senior Clinical Trial Manager position?

This information is not specified in the job description.

Is this a remote position or where is it located?

This information is not specified in the job description.

What skills and experience are required for this role?

Candidates need a BA/BS in a science-related field with 8+ years of relevant work experience in oncology trials, including prior experience as a study lead, and strong knowledge of clinical trial management.

What is the company culture like at Arcellx?

Arcellx fosters a fun, diverse, supportive, and informal environment with core values including Character, Audacity, Determination, Collaboration, and Originality, emphasizing high-performing, inclusive, and collaborative work.

What makes a strong candidate for this Senior Clinical Trial Manager role?

Strong candidates demonstrate alignment with Arcellx's core values, bring diverse backgrounds and viewpoints, and have a BA/BS in a science-related field with 8+ years in oncology trials including study lead experience.

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Fully-Paid Parental Leave
Tuition Reimbursement
Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI